A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Clinical Trial Assessing the Effectiveness and Safety of GUGGULCERA in the Treatment of Mild to Severe Acne Vulgaris and amelioration of skin health.

Vidya Herbs Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Male or female aged 18 â?? 40 years of age both inclusive in general good health
•Must have a definite clinical diagnosis of mild to severe acne vulgaris Grade 2 Grade 3 or Grade 4
•on the Investigators Global Assessment IGA of acne severity 1
•Must be willing and able to give informed consent and comply with the study procedures
•Female patients of childbearing potential must have been using accepted methods of birth control or must agree to continue to practice abstinence from 30 days prior to study entry to 30 days after the last administration of study drug

•1.Known conditions that may interfere with the evaluation of acne vulgaris. Such conditions include but are not limited to the following: rosacea; seborrheic dermatitis; perioral dermatitis; corticosteroid-induced acne or folliculitis; carcinoid syndrome; squamous cell carcinoma; mastocytosis; acneiform eruptions caused by make-up or medication; bacterial folliculitis; facial psoriasis; and facial eczema.
•2.Subjects allergic to herbal products or any component of the study product
•3.Subjects who have been treated topical or oral corticosteroids within 14 days prior to baseline
•4.History of uncontrolled disease or immune deficient disorder
•5.Any feature in the test areas (face) that according to the investigator may influence the results, for example, but not limited to moles, tattoos, scars, irritated skin, scratches, cuts and excess hair
•6.Known HIV or Hepatitis B positive or any other immuno-compromised state
•7.Female subjects who are pregnant, nursing or planning to become pregnant during study participation
•8.Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study
•9.Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study

发起方